"We Envision Growth Strategies Most Suited
to Your Business"

Dermatitis Drugs Market USD 13,630.8 Million at 10.2% CAGR Forecast by 2026

June 25, 2019 | Healthcare

The Global Dermatitis Drugs Market will gain traction in the coming years due to a host of ongoing clinical trials, aimed at molecular improvements in drug manufacturing. According to a report published by Fortune Business Insights, titled “Dermatitis Drugs: Global Market Analysis, Insights, And Forecast, 2019-2026,” the market was valued at US$ 6,097.4 Mn in 2018. Fortune Business Insights predicts that the market will rise impressively at a CAGR of 10.2% and reach US$ 13,630.8 Mn by the end of 2026.


The effects on dermatitis and the high prevalence of atopic dermatitis have led to an increase in awareness for early detection and prevention. Dermatitis can lead to severe skin rashes, redness, itching and can also lead to disorders such as high skin sensitivity and low immunity.


Influenced by the severity of dermatitis, many companies have shifted their focus on the prevention of dermatitis at an early stage and discovering newer drugs that will stop severe cases of dermatitis. The advent of newer drugs with flexible uses has led to a rising uptake and the high adoption will lead to subsequent growth of the global dermatitis drugs market.


Corticosteroids Will Witness High Demand


Among all product types, the corticosteroids segment accounted for the highest market share in 2018. The applications of corticosteroids in the treatment of atopic dermatitis has created a surge in demand for the product across the world. Corticosteroids is a first-line therapy for the treatment of dermatitis and influenced by the high demand, Fortune Business Insights has predicted that this product will witness high demand in the coming years.


As of 2018, corticosteroids have accounted for 63.6% of the global market share. Having said that there has been a growing emphasis on the research and development of various other drug classes such as PDE4 and biologics. This, in turn, will create a high demand for PDE4 and biologics in the coming years, and Fortune Business Insights has predicted that these products will witness a relatively high CAGR in the coming years.


Increasing Drug Approvals Will Favor Growth of the Market in the Asia Pacific


North America has dominated the global dermatitis drugs market in recent years, owing to an improved distribution channel of drugs in the United States and Canada. Furthermore, the high prevalence of atopic dermatitis in the United States will favor the growth of the market in the coming years, and accounting to this, North America is expected to emerge dominant in the forecast period as well.


Having said that, proactive government contributions in the Asia Pacific will favor the regional market. The growing emphasis on introducing innovative therapies for dermatitis by government organizations will boost the dermatitis market in the Asia Pacific. According to Fortune Business Insights, the dermatitis market in Asia Pacific will witness a relatively high CAGR during the forecast period.


The report provides an in-depth analysis of key company activities and focuses on several product launches, mergers and acquisitions, and new investments by some of the most renowned companies. Some of the leading companies that are operating in the global dermatitis market are Valeant Pharmaceuticals, Astellas Pharma US, Inc., Pfizer, Inc., Mylan, Bayer AG, Allergan, LEO Pharma, Regeneron Pharmaceuticals, Inc., and Anacor Pharmaceuticals, Inc.


Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/dermatitis-drugs-market-100658


The global dermatitis market is segmented based on:


























ATTRIBUTE



 DETAILS



Drug Class




  • Calcineurin Inhibitors

  • PDE4 Inhibitors

  • Corticosteroids

  • Biologics

  • Others



By Disease Indication




  • Atopic Dermatitis

  • Contact Dermatitis

  • Others



By Distribution Channel




  • Hospital Pharmacy

  • Retail Pharmacy

  • Online Pharmacy



By Geography




  • North America (USA and Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

  • Rest of World


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X